Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Plos One|April 6, 2012
Heparanase affects food intake and regulates energy balance in miceLinda Karlsson-Lindahl, Linnéa Schmidt, David Haage, et al.
Expert Opinion on Therapeutic Targets|June 25, 2021
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromesEdward Richardson, David García-Bernal, Eleonora Calabretta, et al.
The American Journal of Pathology|February 14, 2016
Heparanase Is Essential for the Development of Acute Experimental GlomerulonephritisMarjolein Garsen, Marilen Benner, Henry B Dijkman, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2020
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapyTali Voloshin, Noa Kaynan, Shiri Davidi, et al.
Cancer Research|October 22, 2009
Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosisChristoph Domschke, Florian Schuetz, Yingzi Ge, et al.
International Journal of Cancer|August 26, 2016
Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivoTali Voloshin, Mijal Munster, Roni Blatt, et al.
Blood|May 31, 2007
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyYang Yang, Veronica MacLeod, Yuemeng Dai, et al.
Cancers|June 24, 2022
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In VivoShiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Cancers|February 25, 2023
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Diabetes|December 22, 2016
Heparanase Overexpression Induces Glucagon Resistance and Protects Animals From Chemically Induced DiabetesDahai Zhang, Fulong Wang, Nathaniel Lal, et al.
Pageof 31